Oxygen regulator subject to MHRA (Medicines and Healthcare products Regulatory Agency) withdrawal:
This article was originally published in Clinica
Executive Summary
Emergency oxygen systems with integral pressure regulators manufactured by the now defunct SOS Ltd and Medical Gas Services are being removed from use in the UK, in light of a risk of fire or explosion. Following two documented incidents where the regulator ignited as it was being turned on, the Medicines and Healthcare products Regulatory Agency (MHRA) believes that the design of the integral regulator involved is "inappropriate". SOS and Medical Gas Services (Bagillt, North Wales) are both in liquidation; their assets have been acquired by Medical Gas Solutions. Queries are being handled by the British Compressed Gases Association (Wallingford, Oxford).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.